Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-26-016535·CITADEL ADVISORS LLC
Schedule 13G ownership disclosure
Inspire Medical Systems Inc
Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 457730109
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Citadel Advisors LLC
Shares: 174,644.00 · Class: 0.6%
- Citadel Advisors Holdings LP
Shares: 174,644.00 · Class: 0.6%
- Citadel GP LLC
Shares: 174,644.00 · Class: 0.6%
- Citadel Securities LLC
Shares: 155,467.00 · Class: 0.5%
- Citadel Securities Group LP
Shares: 352,573.00 · Class: 1.2%
- Citadel Securities GP LLC
Shares: 352,573.00 · Class: 1.2%
- Kenneth Griffin
Shares: 527,217.00 · Class: 1.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-016535
- Form type
- SCHEDULE 13G/A
- Filer
- CITADEL ADVISORS LLC
- CIK
- CIK 1423053
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership